Principal research consultant of MMGC is Dr. Trudy Wassenaar, with expertise in the fields listed below. In addition, partners with excellent knowledge on graphic design, taxonomy, web performance and bioinformatics can be called upon when needed.
With over 20 years of experience in scientific consulting there are few problems that the founder of MMGC can't solve. The subject areas of microbiology she has been involved in are diverse and cover both molecular biology and genetics/genomics of bacteria and viruses. Her List of Publications speaks for itself.
1998-present: Founder of MMGC and principal research consultant in academic and applied microbiological research. Research consulting is carried out by intensive Email contact, web conferencing and regular personal visits.
2015-2016: Part-time associate professor at ORLN, Oak Ridge, TN, USA.
2005-2009: Part-time associate professor at the Center for Biological Sequence Analysis, Danish Technical University (DTU), Lyngby, Denmark.
International research experience: three-month research visits were spent at the University of Cape Town, South Africa; at the RMIT University in Melbourne, Australia; at the South-African National Bioinformatic Institute, Belleville, South Africa; and at ID-DLO in Lelystad, the Netherlands.
1993-1998: Research fellow at the Johannes Gutenberg University of Mainz (Germany), Institute for Medical Microbiology. Subjects of Research: heat shock and porin genes of Salmonella, hemolysin genes of E. coli and V. cholerae, and nearly all aspects of Campylobacter: molecular genetic characterization of virulence and colonization properties, genotyping methods, genetic instability, genomics, population genetics.
1989-1993: Ph.D., later Postdoctoral Fellow, University of Utrecht, Faculty of Veterinary Medicine, the Netherlands. Subject of Research: motility genes of Campylobacter jejuni.
1984-1989: Laboratory assistant at the Free University in Amsterdam, Department of Biochemistry, the Netherlands. Subject of Research: coordinated ribosomal protein biosynthesis in Saccharomyces cerevisiae.
Trudy Wassenaar isa member of the Editorial board of:
Journal of Applied Microbiolgy
Letters of Applied Microbiology
She is a referee for a number of journals, including:
Microbiology UK
Gut Pathogens
Antimicrobial Resistance and Infection Control
PLoS One
Applied and Environmental Microbiology
Journal of Applied Microbiology
Medical Microbiology and Immunology
Emerging Infectious Diseases
Journal of Infectious Diseases
She has acted as a referee for chapters in the following books: Environmental Microbiology and Ecology (Blackwell); Campylobacter, 2nd Edition (ASM Press).
External examiner of Ph.D. theses from: RMIT University, Sydney, Australia; Utrecht University, The Netherlands; University of Cape Town, South Africa, Complutensa University of Madrid (UCM), Madrid, Spain.
Member of the American Society for Microbiology, Deutsche Gesellschaft für Hygiene und Mikrobiologie, Society for General Microbiology, Society for Applied Microbiology.
References from academic colleagues or one of our clients can be provided upon request.
Trudy Wassenaar
With over 20 years of experience in scientific consulting there are few problems that the founder of MMGC can't solve. The subject areas of microbiology she has been involved in are diverse and cover both molecular biology and genetics/genomics of bacteria and viruses. Her List of Publications speaks for itself.
We performed a thorough analysis of Hepatitis A virus and discovered that this virus most likely had an ancestor virus replicating in insects. The work was initiated by MMGC in collaboration with colleagues from UAMS.
Past vaccination with BCG (Tuberculosis) does not protect against Covid-19
In spite of publications in top journals predicting otherwise, an analysis of international data clearly indicated lack of protection. The work was initiated by MMGC in collaboration with independent scolars. The findings were published as early as July 2020 here, and lack of protection by GCG was later confirmed by other research group in clinical trials. That is not to say that vaccination doesn't work: the internationally approved SARS-CoV-2 vaccines are highly effective to prevent severe disease and death.